Title:
ビュープロピオン代謝物質ならびにその合成方法および使用
Document Type and Number:
Japanese Patent JP4664505
Kind Code:
B2
Abstract:
Methods and compositions are disclosed which utilize metabolites of bubropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, but are not limited to, erectile dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. The invention further discloses methods of making optically pure bupropion metabolites.
Inventors:
Gercy, Thomas, Pea.
McCraw, John, Earl.
Senana Yak, Krisanza, H.
Fan, Kun, Kay.
McCraw, John, Earl.
Senana Yak, Krisanza, H.
Fan, Kun, Kay.
Application Number:
JP2000602018A
Publication Date:
April 06, 2011
Filing Date:
February 29, 2000
Export Citation:
Assignee:
Sanovion Pharmaceuticals, Inc.
International Classes:
A61K31/133; A61K31/5375; A61K31/00; A61K31/135; A61K31/137; A61K31/165; A61K31/415; A61K31/4178; A61K31/43; A61K31/435; A61K31/4375; A61K31/439; A61K31/4427; A61K31/46; A61K31/465; A61K31/50; A61K31/53; A61K31/535; A61K45/00; A61K45/06; A61P13/10; A61P15/10; A61P25/00; A61P25/08; A61P25/16; A61P25/24; A61P25/34; A61P43/00; C07C45/51; C07C45/63; C07C49/76; C07C49/807; C07C49/82; C07C49/84; C07C213/00; C07C215/30; C07C225/16; C07C317/14; C07D265/32
Foreign References:
WO1999037305A1 |
Attorney, Agent or Firm:
Yusuke Hiraki
Satoshi Fujita
Yumi Naito
Satoshi Fujita
Yumi Naito